RESOURCES > Federal Register Notices > Rules - 2012
Rules - 2012
Drug Scheduling Actions
Proposed Rule: Placement of Lorcaserin Into Schedule IV (December 19, 2012)
Final Order: Extension of Temporary Placement of Methylone Into Schedule I of the Controlled Substances Act (October 18, 2012)
Proposed Rule: Placement of Methylone Into Schedule I (October 17, 2012)
Final Rule: Classification of Two Steroids, Prostanozol and Methasterone, as Schedule III Anabolic Steroids Under the Controlled Substances Act (July 30, 2012)
Proposed Rule: Placement of Five Synthetic Cannabinoids Into Schedule I (March 1, 2012)
Final Order: Extension of Temporary Placement of Five Synthetic Cannabinoids Into Schedule I of the Controlled Substances Act (February 29, 2012)
Electronic Prescriptions for Controlled Substances
Correction: Definitions Relating to Electronic Orders and Prescriptions for Controlled Substances (September 24, 2012)
Notice: Electronic Prescriptions for Controlled Substances Notice of Approved Certification Process (August 1, 2012)
General
Proposed Rule: Disposal of Controlled Substances (December 21, 2012)
Final Rule: Consolidation of Seizure and Forfeiture Regulations (September 12, 2012)
Final Rule: Technical Amendments and Corrections to DEA Regulations (January 27, 2012)
Registration
Final Rule: Controlled Substances and List I Chemical Registration and Reregistration Fees (March 15, 2012)
Supporting and Related Material:
New Registrant Fee Schedule Calculations - Diversion Control Fee Account (PDF) (March 12, 2012)
ECONOMIC IMPACT ANALYSIS of Final Rule on Controlled Substances and List I Chemical Registration and Reregistration Fees, DEA-346 (PDF) (March 12, 2012)
DEA Registrant Letter (PDF) (March 12, 2012)
Registration Fees Fact Sheet (PDF) (March 12, 2012)
NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).